Amylin Pharmaceuticals (AMLN): Q4 EPS of -$0.13 beats by $0.19. Revenue of $174M (-6% Y/Y)...

|By:, SA News Editor
Amylin Pharmaceuticals (AMLN): Q4 EPS of -$0.13 beats by $0.19. Revenue of $174M (-6% Y/Y) misses by $16M. (PR)